Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06185374 · ClinicalTrials.gov registry record · NA

Text Messaging to Improve Adherence To Repeat Colonoscopy In a Veterans Affairs (VA) Hospital

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT06185374: Completed NA study, sponsored by NYU Langone Health.

NCT06185374 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06185374, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

Colorectal cancer is a common but preventable condition, and increasing colorectal cancer screening is one of the most impactful public health contributions in the field of gastroenterology. Text messaging is a simple, cheap, and rapid method to reach patients that may improve adherence to colonoscopy appointments as well as simplify the process of bowel preparation. The purpose of the study is to evaluate the feasibility of a pilot bidirectional text messaging intervention on attendance for screening/surveillance colonoscopy and bowel preparation quality at an urban VA hospital. The goal is to improve adherence to colonoscopy among patients who are due for a repeat colonoscopy.

Primary Outcome

7-item assessment of participant satisfaction with the "Annie" text intervention. Items are rated on a 5-point scale from 1 (strongly disagree) to 5 (strongly agree). The total score is the sum of responses and ranges from 7 to 35; higher scores indicate greater satisfaction with the intervention.

Interventions

  • BEHAVIORAL Text Message Instructions/Motivation

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-02-27
Est. Completion 2024-08-15
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT06185374 record still lists

NCT06185374 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Text Message Instructions/Motivation is the first listed.

NCT06185374 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06185374 about?

NCT06185374 is a clinical study titled "Text Messaging to Improve Adherence To Repeat Colonoscopy In a Veterans Affairs (VA) Hospital". Colorectal cancer is a common but preventable condition, and increasing colorectal cancer screening is one of the most impactful public health contributions in the field of gastroenterology. Text messaging is a simple, cheap, and rapid method to reach patients that may improve adherence to colonosco...

What is the current status of trial NCT06185374?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2024-02-27. Estimated completion is 2024-08-15.

What interventions are being tested in trial NCT06185374?

The interventions under investigation include: Text Message Instructions/Motivation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06185374?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06185374's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06185374, the US trial registry maintained by the National Library of Medicine. NCT06185374 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.